Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ANIX |
---|---|---|
09:32 ET | 286 | 2.5152 |
09:36 ET | 400 | 2.49 |
09:39 ET | 427 | 2.54 |
09:45 ET | 100 | 2.61 |
10:03 ET | 100 | 2.61 |
10:28 ET | 100 | 2.55 |
10:30 ET | 200 | 2.535 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Anixa Biosciences Inc | 81.0M | -7.3x | --- |
Serina Therapeutics Inc | 79.9M | -0.7x | --- |
Sellas Life Sciences Group Inc | 80.9M | -1.3x | --- |
IO Biotech Inc | 81.7M | -0.7x | --- |
Entera Bio Ltd | 82.7M | -8.1x | --- |
Cognition Therapeutics Inc | 78.9M | -2.1x | --- |
Anixa Biosciences, Inc. is a biotechnology company developing vaccines and therapies that are focused on critical unmet needs in oncology. Its segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Other. Its vaccine programs include the development of a preventative vaccine against triple negative breast cancer (TNBC), the most lethal form of breast cancer, as well as other forms of breast cancer and the development of a preventative vaccine against ovarian cancer. Its therapeutics programs include the development of a chimeric endocrine receptor T cell therapy, a novel form of chimeric antigen receptor T cell (CAR-T) technology, initially focused on treating ovarian cancer, which is being developed by its subsidiary, Certainty Therapeutics, Inc. (Certainty). Certainty is developing immuno-therapy drugs against cancer. The Company’s vaccine portfolio consists of technology focused on the immunization against specific retired proteins.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $81.0M |
---|---|
Revenue (TTM) | $210.0K |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.87 |
EPS | $-0.35 |
Book Value | $0.78 |
P/E Ratio | -7.3x |
Price/Sales (TTM) | 385.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -5,744.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.